Article Information
History
- January 28, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Saikat Basu1,*,
- Mohammad Mehedi Hasan Akash1,
- Yueying Lao2,
- Pallavi A Balivada2,
- Phoebe Ato2,
- Nogaye K Ka2,
- Austin Mituniewicz3,
- Zachary Silfen2,
- Julie Suman4,
- Arijit Chakravarty5 and
- Diane Joseph-McCarthy2,6
- 1Department of Mechanical Engineering, South Dakota State University, Brookings, SD 57007, United States
- 2Department of Biomedical Engineering, Boston University, MA 02215, United States
- 3Joint Department of Biomedical Engineering, University of North Carolina – North Carolina State University, Chapel Hill, NC 27599, United States
- 4Next Breath – an Aptar Pharma Company, Baltimore, MD 21227, United States
- 5Fractal Therapeutics, Cambridge, MA 02319, United States
- 6Bioengineering Technology and Entrepreneurship Center, Boston University, MA 02215, United States
- ↵*E-mail: Saikat.Basu{at}sdstate.edu
Posted January 28, 2022.
A model-based approach to improve intranasal sprays for respiratory viral infections
